Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients

Endocrine

Volumn 36, Issue 2, 2009, Pages 268-274

  Chao, Menglei ^a   Zou, Dajin ^b   Zhang, Yifei ^a   Chen, Yuhong ^a   Wang, Miao ^b   Wu, Hong ^b   Ning, Guang ^a   Wang, Weiqing ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glucose disposal rate; Insulin resistance; Traditional Chinese medicine; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HERBACEOUS AGENT; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTRAGALUS MEMBRANACEUS; CHEMISTRY; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPTIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN RESISTANCE; LONICERA; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ASTRAGALUS MEMBRANACEUS; COPTIS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LONICERA; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PLACEBOS; YOUNG ADULT;

EID: 73349095011     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9222-y     Document Type: Article

References (20)

1. International Diabetes Federation, Diabetes Atlas, 3rd edn. (International Diabetes Federation, Brussels, 2006)
2. E.S. Ford, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 28, 1769-1778 (2005)
3. G. Ravaglia, P. Forti, F. Maioli, Metabolic syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 9, 2471-2476 (2006)
4. N. Qing, C. Shi-bo, Z. Xue-zhong, Analysis on characteristics of the complication of metabolic syndrome in type 2 diabetes patients. J. Tradit. Chin. Med. 9, 809-811 (2007). [article in Chinese]
5. L. Ji-lin, The herbalism analysis of berberine on diabetes. J. Sichuan Tradit. Med. 11, 17-19 (1999). [article in Chinese]
6. S. Zhu-fang, X. Ming-zhi, L. Hai-fan, The effect of Jinqi tablet on glucose metabolism in experimental animals. Tradit. Chin. Drug Res. Clin. Pharmacol. 7, 24-26 (1996). [article in Chinese]
7. S. Zhu-fang, X. Ming-zhi, L. Hai-fan, The effects of Jinqi tablets on lipid, insulin resistance and immunologic function in experimental animals. Tradit. Chin. Drug Res. Clin. Pharmacol. 8, 23-25 (1997). [article in Chinese]
8. M. Vray, J.R. Attali, Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Diabete Metab. 21, 433-439 (1995). http://www.ncbi.nlm.nih.gov/sites/entrez
9. K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(53), 9-553 (1998)
10. Y.F. Zhang, J. Hong, W.W. Zhan, Elevated serum level of interleukin-18 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 29, 419-423 (2006)
11. R.A. Defronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237, E214-E223 (1979)
12. S. Soonthornpun, W. Setasuban, A. Thamprasit, Novel insulin sensitivity index derived from oral glucose tolerance test. J. Clin. Endocrinol. Metab. 88, 1019-1023 (2003)
13. Y. Zhang, X. Li, D. Zou, Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J. Clin. Endocrinol. Metab. 93, 2559-2565 (2008)
14. W. Kong, J. Wei, P. Abidi, Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351 (2004)
15. Y.S. Lee, W.S. Kim, K.H. Kim, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistance states. Diabetes 55, 2256-2264 (2006)
16. N. Turner, J.Y. Li, A. Gosby, Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57, 1414-1418 (2008)
17. J. Yin, R. Hu, M. Chen, Effects of berberine on glucose metabolism in vitro. Metabolism 51, 1439-1443 (2002)
18. L. Zhou, Y. Yang, X. Wang, Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism 56, 405-412 (2007)
19. G.Y. Pan, Z.J. Huang, G.J. Wang, The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med. 69, 632-636 (2003)
20. T.E. Graham, Q. Yang, M. Bluher, Retimol-binding protein 4 and insulin resistance in lean, obese and diabetic subjects. N. Engl. J. Med. 354, 2552-2563 (2006)